Novella taps new oncology chief; Industry prizes data security over productivity;

> Novella Clinical, now a subsidiary of Quintiles ($Q), has appointed Lynne Bui to serve as medical director for its oncology division. News

> According to a survey, the drug development industry is focusing heavily on data security at the cost of using databases to bolster business. Story

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.